Sign Up

    BLFE

    COM:BIOLIFESCIENCES

    BioLife Sciences

    • Stock

    USD

    Last Close

    0.00

    17/04 20:00

    Market Cap

    118

    Beta: -

    Volume Today

    50

    Avg: -

    OverviewMetricsFinancialsAPI
    Income StatementBalance SheetCash FlowKey MetricsRatios
    Quarterly
    Yearly

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Nov '19
    Nov '20
    Nov '21
    Nov '22
    net income
    -1.13K
    -
    -1.27M
    111,693.47%
    depreciation and amortization
    deferred income tax
    stock based compensation
    change in working capital
    1.15K
    -
    379.11K
    32,837.62%
    accounts receivables
    inventory
    18
    -
    accounts payables
    1.15K
    -
    414.97K
    35,952.74%
    other working capital
    -35.87K
    -
    other non cash items
    -0.00
    -
    4.32K
    4,340,746,247,987,902,464%
    net cash provided by operating activities
    17.00
    -
    -884.31K
    5,201,911.76%
    investments in property plant and equipment
    -961
    -
    acquisitions net
    purchases of investments
    sales maturities of investments
    other investing activites
    net cash used for investing activites
    -961
    -
    debt repayment
    -875.80K
    -
    common stock issued
    common stock repurchased
    dividends paid
    other financing activites
    net cash used provided by financing activities
    875.80K
    -
    effect of forex changes on cash
    44.19K
    -
    net change in cash
    -1.30K
    -
    34.72K
    2,764.85%
    cash at beginning of period
    1.32K
    -
    17
    98.71%
    34.74K
    204,252.94%
    cash at end of period
    17
    -
    34.74K
    204,252.94%
    34.74K
    0%
    operating cash flow
    17.00
    -
    -884.31K
    5,201,911.76%
    capital expenditure
    -961
    -
    free cash flow
    17.00
    -
    -885.27K
    5,207,564.71%

    All numbers in USD (except ratios and percentages)